Tony Michael Argenbright

Array ( [id] => 4432076 [patent_doc_number] => 07968511 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis' [patent_app_type] => utility [patent_app_number] => 10/556454 [patent_app_country] => US [patent_app_date] => 2004-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6066 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968511.pdf [firstpage_image] =>[orig_patent_app_number] => 10556454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275158 [patent_doc_number] => 20040234609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Repeat sequence protein polymer active agent congjugates, methods and uses' [patent_app_type] => new [patent_app_number] => 10/845936 [patent_app_country] => US [patent_app_date] => 2004-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14890 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234609.pdf [firstpage_image] =>[orig_patent_app_number] => 10845936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7329784 [patent_doc_number] => 20040254112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Use of pulmonary surfactant for the early treatment of acute pulmonary diseases' [patent_app_type] => new [patent_app_number] => 10/837604 [patent_app_country] => US [patent_app_date] => 2004-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5156 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254112.pdf [firstpage_image] =>[orig_patent_app_number] => 10837604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7033643 [patent_doc_number] => 20050032153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Control of cyanate in aqueous urea solutions by non-1,2-ethylene diamine like compounds for the protection of protein/peptide carbamylation' [patent_app_type] => utility [patent_app_number] => 10/836879 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5364 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032153.pdf [firstpage_image] =>[orig_patent_app_number] => 10836879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122941 [patent_doc_number] => 20050014770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Use of dipyridamole or mopidamole for treatment and prevention of thromboembolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors' [patent_app_type] => utility [patent_app_number] => 10/830294 [patent_app_country] => US [patent_app_date] => 2004-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5052 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014770.pdf [firstpage_image] =>[orig_patent_app_number] => 10830294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7593205 [patent_doc_number] => 07651995 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-26 [patent_title] => 'Absorption enhancers such as e.g. BHT, BHA or propyl gallate' [patent_app_type] => utility [patent_app_number] => 10/553324 [patent_app_country] => US [patent_app_date] => 2004-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5731 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/651/07651995.pdf [firstpage_image] =>[orig_patent_app_number] => 10553324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7116615 [patent_doc_number] => 20050069916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Ultra-sensitive detection systems' [patent_app_type] => utility [patent_app_number] => 10/825568 [patent_app_country] => US [patent_app_date] => 2004-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 96387 [patent_no_of_claims] => 521 [patent_no_of_ind_claims] => 66 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20050069916.pdf [firstpage_image] =>[orig_patent_app_number] => 10825568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7297186 [patent_doc_number] => 20040214754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Ophthalmic preparation containing glycomacropeptide' [patent_app_type] => new [patent_app_number] => 10/813998 [patent_app_country] => US [patent_app_date] => 2004-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7817 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214754.pdf [firstpage_image] =>[orig_patent_app_number] => 10813998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7377651 [patent_doc_number] => 20040220089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Ophthalmic preparation containing glycoprotein' [patent_app_type] => new [patent_app_number] => 10/814001 [patent_app_country] => US [patent_app_date] => 2004-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10367 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220089.pdf [firstpage_image] =>[orig_patent_app_number] => 10814001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667581 [patent_doc_number] => 20060172931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Heparin-binding peptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/551005 [patent_app_country] => US [patent_app_date] => 2004-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 23006 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172931.pdf [firstpage_image] =>[orig_patent_app_number] => 10551005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 380114 [patent_doc_number] => 07309689 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-18 [patent_title] => 'Sustained peptide-release formulation' [patent_app_type] => utility [patent_app_number] => 10/808504 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 4433 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/309/07309689.pdf [firstpage_image] =>[orig_patent_app_number] => 10808504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122848 [patent_doc_number] => 20050014677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Solid peptide preparations for inhalation and their preparation' [patent_app_type] => utility [patent_app_number] => 10/808239 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6156 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014677.pdf [firstpage_image] =>[orig_patent_app_number] => 10808239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5678336 [patent_doc_number] => 20060183692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy' [patent_app_type] => utility [patent_app_number] => 10/550154 [patent_app_country] => US [patent_app_date] => 2004-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4744 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183692.pdf [firstpage_image] =>[orig_patent_app_number] => 10550154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 217123 [patent_doc_number] => 07612033 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'Methods for delivering compounds into a cell' [patent_app_type] => utility [patent_app_number] => 10/802919 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23537 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 355 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/612/07612033.pdf [firstpage_image] =>[orig_patent_app_number] => 10802919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4547643 [patent_doc_number] => 07960334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Use of ADNF III polypeptides for treating mental diseases and disorders, including schizophrenia' [patent_app_type] => utility [patent_app_number] => 10/547986 [patent_app_country] => US [patent_app_date] => 2004-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15465 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/960/07960334.pdf [firstpage_image] =>[orig_patent_app_number] => 10547986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677093 [patent_doc_number] => 20040152733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Duloxetine for treatment of hot flashes' [patent_app_type] => new [patent_app_number] => 10/473634 [patent_app_country] => US [patent_app_date] => 2004-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2586 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152733.pdf [firstpage_image] =>[orig_patent_app_number] => 10473634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 574285 [patent_doc_number] => 07459425 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-02 [patent_title] => 'Reagents for protection of peptide/proteins carbamylation in urea solutions utilizing non-ethylene-diamine like compounds' [patent_app_type] => utility [patent_app_number] => 10/785369 [patent_app_country] => US [patent_app_date] => 2004-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5023 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/459/07459425.pdf [firstpage_image] =>[orig_patent_app_number] => 10785369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4832883 [patent_doc_number] => 20080131430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Therapeutic Administration Of The Scrambled Anti-Angiogenic Peptide C16Y' [patent_app_type] => utility [patent_app_number] => 10/588884 [patent_app_country] => US [patent_app_date] => 2004-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10295 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131430.pdf [firstpage_image] =>[orig_patent_app_number] => 10588884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5643218 [patent_doc_number] => 20060281673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Novel peptide inhibitor of hiv fusion that disrupts the internal trimeric coiled-coil of gp41' [patent_app_type] => utility [patent_app_number] => 10/544115 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15737 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281673.pdf [firstpage_image] =>[orig_patent_app_number] => 10544115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005690 [patent_doc_number] => 20050171003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Use of a growth hormone or a growth hormone secretagogue for appetite-suppression or induction of satiety' [patent_app_type] => utility [patent_app_number] => 10/772997 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4818 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171003.pdf [firstpage_image] =>[orig_patent_app_number] => 10772997 [rel_patent_id] =>[rel_patent_doc_number] =>)